Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) Invested Capital (2020 - 2025)

Incannex Healthcare's Invested Capital history spans 5 years, with the latest figure at $73.4 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 2091.88% year-over-year to $73.4 million; the TTM value through Dec 2025 reached $73.4 million, up 2091.88%, while the annual FY2025 figure was $13.4 million, 19.36% up from the prior year.
  • Invested Capital for Q4 2025 was $73.4 million at Incannex Healthcare, down from $77.0 million in the prior quarter.
  • Across five years, Invested Capital topped out at $77.0 million in Q3 2025 and bottomed at $3.3 million in Q4 2024.
  • The 4-year median for Invested Capital is $13.4 million (2025), against an average of $23.2 million.
  • The largest annual shift saw Invested Capital tumbled 82.25% in 2024 before it skyrocketed 2091.88% in 2025.
  • A 4-year view of Invested Capital shows it stood at $8.6 million in 2021, then skyrocketed by 120.11% to $18.9 million in 2023, then crashed by 82.25% to $3.3 million in 2024, then surged by 2091.88% to $73.4 million in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Invested Capital are $73.4 million (Q4 2025), $77.0 million (Q3 2025), and $13.4 million (Q2 2025).